Here are relevant reports on : pet-supplements-market
-
Probiotic Yeast Market by Product Type (Functional Food & Beverages, Dietary Supplements, Animal Feed), Yeast Strain Type (Saccharomyces boulardii, Saccharomyces cerevisiae, Others), End User, Distribution Channel, and Region - Global Forecast to 2030
The global probiotic yeast market is expected to grow from USD 10.21 billion in 2025 to USD 16.23 billion by 2030, at a compound annual growth rate (CAGR) of 9.7% during the forecast period. The Key Players Lallemand Inc. (Canada), Lesaffre Group (France), DSM-Firmenich (Netherlands), ADM (US), Kerry Group (Ireland), Yakult Honsha Co., Ltd. (Japan), Danone (France), Nestle (Switzerland), Morinaga Milk Industry Co., Ltd. (Japan), and H&H Group (Hong Kong).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Postbiotics Market by Source (Bacteria, Yeast), Application (Functional Food & Beverages, Dietary Supplements, Animal Feed, Cosmetics & Personal Care, and Pharmaceuticals), Form, Function, Manufacturing Technology, and Region - Global Forecast to 2030
The postbiotics market is estimated at USD 146.7 million in 2025 and is projected to reach USD 224.8 million by 2030, at a CAGR of 8.9%. The report profiles key players such as Cargill, Incorporated (US), ADM (US), Kerry Group PLC (Ireland), dsm-firmenich (Netherlands), Associated British Foods plc (UK), BASF (Germany), Novozymes A/S, part of Novonesis Group (Denmark), International Flavors & Fragrances Inc (US), MCLS Europe B.V. (Netherlands), Phileo by Lesaffre (France), Lallemand Inc. (Canada), Sami-Sabinsa Group. (India), CJ CheilJedang Corp. (South Korea), Biotenova Sdn. Bhd. (Malaysia), and Bioprox Healthcare (France).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Softgel Capsules Market by Material, Source (Porcine, Bovine), Application (Pharmaceuticals, Nutraceuticals & Dietary Supplements, Cosmetics & Personal Care), Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028
The global softgel capsules market, valued at US$1.0 billion in 2022, stood at US$1.1 billion in 2023 and is projected to advance at a resilient CAGR of 6.3% from 2023 to 2028, culminating in a forecasted valuation of US$1.5 billion by the end of the period. The growth of this market is majorly driven by the benefits of softgel capsules, increasing demand for dietary supplements and nutraceuticals, and rising demand for naturally sourced ingredients.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Cattle & Porcine/Swine Reproductive Diseases Market by Product (Diagnostics (ELISA, PCR, Rapid Antigen Testing), Pharmaceuticals (Vaccines), Supplements, Animal Type, Disease (BVD, PRRS, Leptospirosis, Brucellosis), End User - Global Forecast to 2029
The global cattle & porcine/swine reproductive diseases market, valued at US$726.9 million in 2023, stood at US$758.2 million in 2024 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2029, culminating in a forecasted valuation of US$975.8 million by the end of the period. Increasing investments, funding, and grants from various governments and organizations to improve animal health, along with a growing number of veterinarians in developing nations, are enhancing the treatment of diseases.
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Europe Dietary Supplements Market by Type (Botanicals, Vitamins, Minerals, Amino Acids, Enzymes, Probiotics), Mode of Application (Tablets, Capsules, Gummies/Chewables), Distribution Channel, Target Consumer, Function, Countries - Forecast to 2030
The Europe dietary supplements market is expected to grow from USD 45.75 billion in 2025 to USD 64.03 billion by 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period. The Key Players Bayer AG (Germany), Nestlé Health Science (Switzerland), Glanbia plc (Ireland), and Haleon Group of Companies (UK).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Medium Chain Triglycerides Market by Fatty Acid Type (Caproic, Caprylic, Capric and Lauric), Application (Nutritional Supplements, Infant Formula, Sports Drinks, Pharmaceutical Products), Form, Source and Region - Global Forecast to 2026
The medium chain triglycerides market was expected to grow from USD 763 million in 2021 to USD 1034 million by 2026, at a CAGR of 6.3% during the forecast period. Key players in this market include BASF SE (Germany), Koninklijke DSM N.V. (the Netherlands), Dupont(US), Lonza Group Ltd(Switzerland), Musim Mas Holdings(Singapore), Croda International Plc(UK), P&G Chemicals (US), Acme-Hardesty Company(Bluebell, PA), Wilmar International Limited( Singapore), Stepan Company (US), Sternchemie GmbH & Co. KG(Germany), Emery Oleochemicals Group(US), KLK Oleo(Malaysia), Nutricia(New Zealand), Connoils (US), Now foods(US), Barleans (Washington), Jarrow formula’s(US), Nutiva(US), Henry Lamotte Oils GmbH (Germany).
- Published: December 2021
- Price: $ 4950
- TOC Available:
-
Fermentation Enabled Alternative Proteins & Supplements Market Report by Process (Precision, Biomass, Traditional), by Microbe (Yeast, Algae, Bacteria, Fungi), By Ingredient, End Use & Region - Global Forecast to 2029
According to MarketsandMarkets, the fermentation enabled alternative proteins & supplements market is projected to reach USD XX billion by 2029, at a CAGR of 39.9% during the forecast period. Key players in this market include Geltor (US), Perfect Day, Inc. (US), The EVERY Co. (US), Impossible Foods Inc. (US), Motif FoodWorks, Inc. (US), Imagindairy Ltd. (Israel), Shiru, Inc. (US), Formo (Germany), Eden Brew (Australia), New Culture (US), Helaina Inc (US), Mycorena (Sweden), Myco Technology (US), Fybraworks Foods (US) and Change Foods (US).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Ear Health Market by Product (Ear Health Devices (Diagnostic Devices, Surgical Devices, Hearing Aids, Hearing Implants, CO2 Lasers), Ear Health Supplements, Ear Infection Drug Treatment), and Region - Global Forecast to 2026
The ear health market is expected to grow from USD 1.4 billion in 2021 to USD 1.9 billion by 2026, at a compound annual growth rate (CAGR) of 6.3% during the forecast period. The prominent players Sonova Holdings AG (Switzerland), Olympus Corp. (Japan), William Demant Holdings A/S (Denmark), Cochlear Limited (Australia), Stryker Corporation (US), Johnson & Johnson (US), Novartis (Switzerland), Karl Storz GMBH & Co. KG (Germany), Medtronic Plc (Ireland), Oscar Remedies Pvt Ltd. (India), and InnerScope Hearing Technologies (US).
- Published: December 2021
- Price: $ 4950
- TOC Available:
-
Europe Probiotics Market by Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Forecast to 2030
The Europe probiotics market is estimated to be USD 15.73 billion in 2025 and is projected to reach USD 20.56 billion by 2030, registering at a CAGR of 5.5% from 2025 to 2030. The key players include Danone S.A. (France), Probi AB (Sweden), Nestlé S.A. (Switzerland), Kerry Group plc (Ireland), BioGaia AB (Sweden), Bio-K Plus International Inc. (Canada), Daflorn Probiotics Ltd. (Bulgaria), Yakult Honsha Co., Ltd. (Japan), Arla Foods (Denmark), and AB-Biotics S.A. (Spain).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Astaxanthin Market by Source (Natural, Synthetic), Form (Dry, Liquid), Method of Production (Microalgae Cultivation, Chemical Synthesis, Fermentation), Application (Dietary Supplements, Food & Beverages, Cosmetics), and Region - Global Forecast to 2026
The global astaxanthin market size was valued to grow from USD 647 million in 2021 to hit USD 965 million by 2026, at a compound annual growth rate (CAGR) of 8.3% during the forecast period. Some of the key players in the market such as Koninklijke DSM N.V. (the Netherlands), BASF SE (Germany), Cyanotech Corporation (US), Otsuka Holdings Co. Ltd. (Japan), Divi’s Laboratories Ltd. (India), Valensa International (US), Fuji Chemical Industries Co. Ltd. (Japan), Beijing Gingko Group (China), Cardax, Inc. (Denmark), Piveg, Inc. (US). Other players in the market are Fenchem Biotek Ltd. (China), Algatech Ltd. (Israel), Supreme Biotechnologies (New Zealand), Igene Biotechnology Inc. (US), Algamo (Czech Republic), Biogenic Co., Ltd. (Japan), Astamaz NZ Ltd. (New Zealand), Algalif (Iceland), Algae to Omega (US), and Algae Health Sciences, Inc. (US).
- Published: August 2021
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
